The groups ask regulators to assess the impact of these businesses on critical drug shortages and for states to regulate them appropriately.
Ambulatory infusion pump sets for use in the United States are in limited supply. NHIA has developed product shortage recommendations to help clinicians manage patients during this time when pump sets may not be readily available.
CMS issued the Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) final rule and is not finalizing its interpretation of the “appropriate for use in the home” requirement in the definition of DME as it applies to certain external infusion pumps.
Please know that NHIA is here to help in whatever ways we can. If your organization is struggling to source supplies, arrange for alternative patient care, understand how emergency declarations and waivers impact your operations, or anything else, feel free to reach out to us.
With Eitan Medical’s global footprint, this strategic partnership expands the international presence within the advisory group and will inform the discussion around bringing connected technology solutions to the home and alternate site infusion industry.
Learn about the new LCDs, what it means for home PEN patients and home providers and the challenges that still exist in home PEN Medicare coverage which will require advocacy from NHIA, ASPEN, home care clinicians and patients.
This strategic partnership between NHIA and PlayMaker Health will bring a unique perspective to the FIAC, adding support for data-driven programs critical to expanding access of home and alternate site infusion.
Advocacy News CMS Issues Multiple Regulations Affecting Home and Alternate Site Infusion November 4, 2021 This week, the Centers for Medicare & Medicaid Services (CMS) released a
Registration is now open for the National Home Infusion Association’s 2022 Annual Conference, to be held March 12-16, 2022, at the Gaylord Opryland Resort & Convention Center in Nashville, Tennessee.
New publicly available data from the Centers for Medicare and Medicaid Services for CY 2019 shows that beneficiary utilization of the Part B DMEPOS home
NHIF Research Rate of Discontinuation from Home Infusion Therapy Due to Adverse Drug Reactions and Unplanned Hospitalizations – A Pilot Study September/October 2021 By Danell
Regulatory update NHIA Submits Comments on Proposed 2022 Physician Fee Schedule September 13, 2021 On September 10, NHIA submitted comments to the Centers for Medicare
This new scholarly journal will feature independent research and studies related to infused therapies, patient outcomes, medication safety, economic analyses, and case studies.
On September 8, a group of stakeholders, including home infusion providers, patient advocacy groups, professional societies, and industry suppliers, sent a letter to leaders in the House of Representatives and the Senate encouraging them to pass the Preserving Patient Access to Home Infusion Act (S 2652; H.R. 5067).
Regulatory update NHIA Comments on Medicare home health proposed rule August 27, 2021 NHIA has submitted comments to CMS on the CY 2022 Home Health
PRESS RELEASE NHIA APPLAUDS HOUSE INTRODUCTION OF BIPARTISAN HOME INFUSION LEGISLATION FOR IMMEDIATE RELEASEContact: Shea McCarthyDirector of Legislative Affairsshea.mccarthy@nhia.org202-285-3866 Alexandria, Va. (August 23, 2021) — Today,
PRESS RELEASE BIPARTISAN LEGISLATION WOULD MAINTAIN HOME INFUSION ACCESS AMONG MEDICARE BENEFICIARIES FOR IMMEDIATE RELEASEContact: Shea McCarthyDirector of Legislative Affairsshea.mccarthy@nhia.org202-285-3866 Alexandria, Va. (August 5, 2021)
The groups ask regulators to assess the impact of these businesses on critical drug shortages and for states to regulate them appropriately.
Ambulatory infusion pump sets for use in the United States are in limited supply. NHIA has developed product shortage recommendations to help clinicians manage patients during this time when pump sets may not be readily available.
CMS issued the Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) final rule and is not finalizing its interpretation of the “appropriate for use in the home” requirement in the definition of DME as it applies to certain external infusion pumps.
Please know that NHIA is here to help in whatever ways we can. If your organization is struggling to source supplies, arrange for alternative patient care, understand how emergency declarations and waivers impact your operations, or anything else, feel free to reach out to us.
With Eitan Medical’s global footprint, this strategic partnership expands the international presence within the advisory group and will inform the discussion around bringing connected technology solutions to the home and alternate site infusion industry.
Learn about the new LCDs, what it means for home PEN patients and home providers and the challenges that still exist in home PEN Medicare coverage which will require advocacy from NHIA, ASPEN, home care clinicians and patients.
This strategic partnership between NHIA and PlayMaker Health will bring a unique perspective to the FIAC, adding support for data-driven programs critical to expanding access of home and alternate site infusion.
Advocacy News CMS Issues Multiple Regulations Affecting Home and Alternate Site Infusion November 4, 2021 This week, the Centers for Medicare & Medicaid Services (CMS) released a
Registration is now open for the National Home Infusion Association’s 2022 Annual Conference, to be held March 12-16, 2022, at the Gaylord Opryland Resort & Convention Center in Nashville, Tennessee.
New publicly available data from the Centers for Medicare and Medicaid Services for CY 2019 shows that beneficiary utilization of the Part B DMEPOS home
NHIF Research Rate of Discontinuation from Home Infusion Therapy Due to Adverse Drug Reactions and Unplanned Hospitalizations – A Pilot Study September/October 2021 By Danell
Regulatory update NHIA Submits Comments on Proposed 2022 Physician Fee Schedule September 13, 2021 On September 10, NHIA submitted comments to the Centers for Medicare
This new scholarly journal will feature independent research and studies related to infused therapies, patient outcomes, medication safety, economic analyses, and case studies.
On September 8, a group of stakeholders, including home infusion providers, patient advocacy groups, professional societies, and industry suppliers, sent a letter to leaders in the House of Representatives and the Senate encouraging them to pass the Preserving Patient Access to Home Infusion Act (S 2652; H.R. 5067).
Regulatory update NHIA Comments on Medicare home health proposed rule August 27, 2021 NHIA has submitted comments to CMS on the CY 2022 Home Health
PRESS RELEASE NHIA APPLAUDS HOUSE INTRODUCTION OF BIPARTISAN HOME INFUSION LEGISLATION FOR IMMEDIATE RELEASEContact: Shea McCarthyDirector of Legislative Affairsshea.mccarthy@nhia.org202-285-3866 Alexandria, Va. (August 23, 2021) — Today,
PRESS RELEASE BIPARTISAN LEGISLATION WOULD MAINTAIN HOME INFUSION ACCESS AMONG MEDICARE BENEFICIARIES FOR IMMEDIATE RELEASEContact: Shea McCarthyDirector of Legislative Affairsshea.mccarthy@nhia.org202-285-3866 Alexandria, Va. (August 5, 2021)
